Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) is a publicly traded Healthcare sector company. As of May 21, 2026, RDY trades at $13.57 with a market cap of $11.32B and a P/E ratio of 0.00. RDY moved +1.23% today. Year to date, RDY is -1.37%; over the trailing twelve months it is -6.00%. Its 52-week range spans $12.19 to $16.19. Analyst consensus is sell with an average price target of $0.00. Rallies surfaces RDY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own RDY include GQG Partners, Panagora Asset, and Centerbook Partners. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Dr. Reddy's Laboratories Limited American Depositary Shares.
| Metric | Value |
|---|---|
| Price | $13.57 |
| Market Cap | $11.32B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.11% |
| 52-Week High | $16.19 |
| 52-Week Low | $12.19 |
| Volume | 330 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover RDY: 0 strong buy, 0 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $0.00.